Flagship Journal

Effect of Hypertension Management on CKD Progression

13 Mins

December 2025

Chronic kidney disease (CKD) is a significant public health concern that leads to higher mortality, increased illness, and reduced quality…

5 Mins

2 May 2022

Varicella Zoster Reactivation Following mRNA Vaccination: Two Case Reports and a Review of Cutaneous Adverse Events of COVID-19 Vaccines

Varicella Zoster reactivation and cutaneous reaction as a mRNA vaccine side effect following COVID 19 vaccination…

7 Mins

22 Mar 2022

Interview: David Oliver

David Oliver shared his thoughts with EMJ on his leadership and policy experience, his passion for advocacy in healthcare, and his work in…

5 Mins

22 Mar 2022

Science Versus COVID-19: What Have We Learnt So Far?

TWO YEARS AGO, the COVID-19 pandemic emerged and swept through the world, going on to have a profound human and health toll…

6 Mins

22 Mar 2022

Editor’s Pick: Thromboembolic Storm in the Recovering Stage of COVID-19: A Case Report

COVID 19 was first identified in late 2019 and led to a worldwide pandemic. Covid complications include thromboembolic storm…

10 Mins

22 Mar 2022

Utility of Evidence-Based Clinical Decision Support in Reducing Unwarranted Variations in Diagnosis and Treatment of Breast and Lung Cancer

It is clear that the delivery of advanced healthcare prolongs life. The global average life expectancy has almost doubled since 1900…

9 Mins

22 Mar 2022

ST Elevation Myocardial Infarction in Patients with COVID-19: Case Series

Patients with COVID 19 with associated myocardial infarction and myocarditis, requiring myocarditis treatment…

8 Mins

22 Mar 2022

Clinical Inertia of Discharge Planning Among Patients with Diabetes in Elhwari General Hospital

Diabetes is one of the most common chronic conditions. It affects a global population of approximately 425 million. The prevalence…

9 Mins

22 Mar 2022

The Impact of Intermediate Antidrug Antibodies to Infliximab and Adalimumab on Clinical Outcomes in Patients with Crohn’s Disease or Ulcerative Colitis

Anti-TNF drugs, adalimumab and infliximab are treatments for inflammatory bowel diseases (IBD), Chron’s disease, ulcerative colitis…

Loading posts...

« Previous 1 … 24 25 26 27 28 … 35 Next »

Flagship Journal

Effect of Hypertension Management on CKD Progression

Varicella Zoster Reactivation Following mRNA Vaccination: Two Case Reports and a Review of Cutaneous Adverse Events of COVID-19 Vaccines

Interview: David Oliver

Science Versus COVID-19: What Have We Learnt So Far?

Editor’s Pick: Thromboembolic Storm in the Recovering Stage of COVID-19: A Case Report

Utility of Evidence-Based Clinical Decision Support in Reducing Unwarranted Variations in Diagnosis and Treatment of Breast and Lung Cancer

ST Elevation Myocardial Infarction in Patients with COVID-19: Case Series

Clinical Inertia of Discharge Planning Among Patients with Diabetes in Elhwari General Hospital

The Impact of Intermediate Antidrug Antibodies to Infliximab and Adalimumab on Clinical Outcomes in Patients with Crohn’s Disease or Ulcerative Colitis

Therapy Area

About Us